PinPoint Cancer Risk Test
Coming soon to Alderley Lighthouse Labs
Alderley Lighthouse Labs is working with PinPoint Data Science to establish access to the PinPoint Cancer Risk Test through Alderley’s laboratory service.
The PinPoint Test is an AI-powered blood-based cancer risk assessment tool. It uses machine learning to analyse standard blood biomarkers and patient information, generating a single risk indicator to support clinical decision-making. The test is a UKCA-marked Software IVD and has been developed and validated using real-world NHS data.
We anticipate that the PinPoint Test will be available through Alderley Lighthouse Labs from September 2026.
Further updates will be provided through our website. If you would like to be contacted directly when the test becomes available, please register your interest below.